Cover Image
Market Research Report

Global Circulating Tumor Cell Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 797250
Published Content info 102 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Circulating Tumor Cell Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 102 Pages
Description

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

In 2018, the global Circulating Tumor Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Circulating Tumor Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cell development in United States, Europe and China.

The key players covered in this study

  • Menarini-Silicon Biosystems
  • Qiagen(Adnagen)
  • Clearbridge Biomedics
  • Celsee
  • Fluidigm
  • ApoCell
  • Greiner Bio-one GmbH
  • Advanced Cell Diagnostics
  • Aviva Biosciences
  • Fluxion Biosciences
  • Sysmex Corporation
  • Epic Sciences
  • Cynvenio
  • CytoTrack
  • Ikonisys
  • Vortex BioSciences
  • Gilupi
  • Biocept
  • ScreenCell
  • ANGLE

Market segment by Type, the product can be split into

  • CTC Enrichment
  • CTC Detection
  • CTC Analysis

Market segment by Application, split into

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Other

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Circulating Tumor Cell status, future forecast, growth opportunity, key market and key players.
  • To present the Circulating Tumor Cell development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cell are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Circulating Tumor Cell Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 CTC Enrichment
    • 1.4.3 CTC Detection
    • 1.4.4 CTC Analysis
  • 1.5 Market by Application
    • 1.5.1 Global Circulating Tumor Cell Market Share by Application (2014-2025)
    • 1.5.2 Breast Cancer
    • 1.5.3 Prostate Cancer
    • 1.5.4 Colorectal Cancer
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Circulating Tumor Cell Market Size
  • 2.2 Circulating Tumor Cell Growth Trends by Regions
    • 2.2.1 Circulating Tumor Cell Market Size by Regions (2014-2025)
    • 2.2.2 Circulating Tumor Cell Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Circulating Tumor Cell Market Size by Manufacturers
    • 3.1.1 Global Circulating Tumor Cell Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Circulating Tumor Cell Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
  • 3.2 Circulating Tumor Cell Key Players Head office and Area Served
  • 3.3 Key Players Circulating Tumor Cell Product/Solution/Service
  • 3.4 Date of Enter into Circulating Tumor Cell Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Circulating Tumor Cell Market Size by Type (2014-2019)
  • 4.2 Global Circulating Tumor Cell Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Circulating Tumor Cell Market Size (2014-2019)
  • 5.2 Circulating Tumor Cell Key Players in United States
  • 5.3 United States Circulating Tumor Cell Market Size by Type
  • 5.4 United States Circulating Tumor Cell Market Size by Application

6 Europe

  • 6.1 Europe Circulating Tumor Cell Market Size (2014-2019)
  • 6.2 Circulating Tumor Cell Key Players in Europe
  • 6.3 Europe Circulating Tumor Cell Market Size by Type
  • 6.4 Europe Circulating Tumor Cell Market Size by Application

7 China

  • 7.1 China Circulating Tumor Cell Market Size (2014-2019)
  • 7.2 Circulating Tumor Cell Key Players in China
  • 7.3 China Circulating Tumor Cell Market Size by Type
  • 7.4 China Circulating Tumor Cell Market Size by Application

8 Japan

  • 8.1 Japan Circulating Tumor Cell Market Size (2014-2019)
  • 8.2 Circulating Tumor Cell Key Players in Japan
  • 8.3 Japan Circulating Tumor Cell Market Size by Type
  • 8.4 Japan Circulating Tumor Cell Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Circulating Tumor Cell Market Size (2014-2019)
  • 9.2 Circulating Tumor Cell Key Players in Southeast Asia
  • 9.3 Southeast Asia Circulating Tumor Cell Market Size by Type
  • 9.4 Southeast Asia Circulating Tumor Cell Market Size by Application

10 India

  • 10.1 India Circulating Tumor Cell Market Size (2014-2019)
  • 10.2 Circulating Tumor Cell Key Players in India
  • 10.3 India Circulating Tumor Cell Market Size by Type
  • 10.4 India Circulating Tumor Cell Market Size by Application

11 Central & South America

  • 11.1 Central & South America Circulating Tumor Cell Market Size (2014-2019)
  • 11.2 Circulating Tumor Cell Key Players in Central & South America
  • 11.3 Central & South America Circulating Tumor Cell Market Size by Type
  • 11.4 Central & South America Circulating Tumor Cell Market Size by Application

12 International Players Profiles

  • 12.1 Menarini-Silicon Biosystems
    • 12.1.1 Menarini-Silicon Biosystems Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Circulating Tumor Cell Introduction
    • 12.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.1.5 Menarini-Silicon Biosystems Recent Development
  • 12.2 Qiagen(Adnagen)
    • 12.2.1 Qiagen(Adnagen) Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Circulating Tumor Cell Introduction
    • 12.2.4 Qiagen(Adnagen) Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.2.5 Qiagen(Adnagen) Recent Development
  • 12.3 Clearbridge Biomedics
    • 12.3.1 Clearbridge Biomedics Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Circulating Tumor Cell Introduction
    • 12.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.3.5 Clearbridge Biomedics Recent Development
  • 12.4 Celsee
    • 12.4.1 Celsee Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Circulating Tumor Cell Introduction
    • 12.4.4 Celsee Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.4.5 Celsee Recent Development
  • 12.5 Fluidigm
    • 12.5.1 Fluidigm Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Circulating Tumor Cell Introduction
    • 12.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.5.5 Fluidigm Recent Development
  • 12.6 ApoCell
    • 12.6.1 ApoCell Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Circulating Tumor Cell Introduction
    • 12.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.6.5 ApoCell Recent Development
  • 12.7 Greiner Bio-one GmbH
    • 12.7.1 Greiner Bio-one GmbH Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Circulating Tumor Cell Introduction
    • 12.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.7.5 Greiner Bio-one GmbH Recent Development
  • 12.8 Advanced Cell Diagnostics
    • 12.8.1 Advanced Cell Diagnostics Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Circulating Tumor Cell Introduction
    • 12.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.8.5 Advanced Cell Diagnostics Recent Development
  • 12.9 Aviva Biosciences
    • 12.9.1 Aviva Biosciences Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Circulating Tumor Cell Introduction
    • 12.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.9.5 Aviva Biosciences Recent Development
  • 12.10 Fluxion Biosciences
    • 12.10.1 Fluxion Biosciences Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Circulating Tumor Cell Introduction
    • 12.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)
    • 12.10.5 Fluxion Biosciences Recent Development
  • 12.11 Sysmex Corporation
  • 12.12 Epic Sciences
  • 12.13 Cynvenio
  • 12.14 CytoTrack
  • 12.15 Ikonisys
  • 12.16 Vortex BioSciences
  • 12.17 Gilupi
  • 12.18 Biocept
  • 12.19 ScreenCell
  • 12.20 ANGLE

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Circulating Tumor Cell Key Market Segments
  • Table Key Players Circulating Tumor Cell Covered
  • Table Global Circulating Tumor Cell Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Circulating Tumor Cell Market Size Market Share by Type 2014-2025
  • Figure CTC Enrichment Figures
  • Table Key Players of CTC Enrichment
  • Figure CTC Detection Figures
  • Table Key Players of CTC Detection
  • Figure CTC Analysis Figures
  • Table Key Players of CTC Analysis
  • Table Global Circulating Tumor Cell Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Breast Cancer Case Studies
  • Figure Prostate Cancer Case Studies
  • Figure Colorectal Cancer Case Studies
  • Figure Other Case Studies
  • Figure Circulating Tumor Cell Report Years Considered
  • Table Global Circulating Tumor Cell Market Size 2014-2025 (Million US$)
  • Figure Global Circulating Tumor Cell Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Circulating Tumor Cell Market Size by Regions 2014-2025 (Million US$)
  • Table Global Circulating Tumor Cell Market Size by Regions 2014-2019 (Million US$)
  • Table Global Circulating Tumor Cell Market Share by Regions 2014-2019
  • Figure Global Circulating Tumor Cell Market Share by Regions 2014-2019
  • Figure Global Circulating Tumor Cell Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Circulating Tumor Cell Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Circulating Tumor Cell Market Share by Manufacturers (2014-2019)
  • Figure Global Circulating Tumor Cell Market Share by Manufacturers in 2018
  • Table Global Circulating Tumor Cell Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Circulating Tumor Cell Product/Solution/Service
  • Table Date of Enter into Circulating Tumor Cell Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table Global Circulating Tumor Cell Market Size Share by Type (2014-2019)
  • Figure Global Circulating Tumor Cell Market Size Market Share by Type (2014-2019)
  • Table Global Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table Global Circulating Tumor Cell Market Size Share by Application (2014-2019)
  • Figure Global Circulating Tumor Cell Market Size Market Share by Application (2014-2019)
  • Figure Global Circulating Tumor Cell Revenue Market Share by Application in 2018
  • Figure United States Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table United States Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table United States Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table United States Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table United States Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table United States Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table United States Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure Europe Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table Europe Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table Europe Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table Europe Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table Europe Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure China Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table China Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table China Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table China Circulating Tumor Cell Market Size by Type (2014-20189) (Million US$)
  • Table China Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table China Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table China Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure Japan Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table Japan Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table Japan Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table Japan Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table Japan Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure Southeast Asia Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table Southeast Asia Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table Southeast Asia Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure India Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table India Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table India Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table India Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table India Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table India Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table India Circulating Tumor Cell Market Share by Application (2014-2019)
  • Figure Central & South America Circulating Tumor Cell Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Circulating Tumor Cell Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Circulating Tumor Cell Market Share (2018-2019)
  • Table Central & South America Circulating Tumor Cell Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Circulating Tumor Cell Market Share by Type (2014-2019)
  • Table Central & South America Circulating Tumor Cell Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Circulating Tumor Cell Market Share by Application (2014-2019)
  • Table Menarini-Silicon Biosystems Company Details
  • Table Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2014-2019) (Million US$)
  • Figure Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Menarini-Silicon Biosystems Recent Development
  • Table Qiagen(Adnagen) Company Details
  • Table Qiagen(Adnagen) Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Qiagen(Adnagen) Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Qiagen(Adnagen) Recent Development
  • Table Clearbridge Biomedics Company Details
  • Table Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Clearbridge Biomedics Recent Development
  • Table Celsee Company Details
  • Table Celsee Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Celsee Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Celsee Recent Development
  • Table Fluidigm Company Details
  • Table Fluidigm Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Fluidigm Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Fluidigm Recent Development
  • Table ApoCell Company Details
  • Table ApoCell Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure ApoCell Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table ApoCell Recent Development
  • Table Greiner Bio-one GmbH Company Details
  • Table Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Greiner Bio-one GmbH Recent Development
  • Table Advanced Cell Diagnostics Company Details
  • Table Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Advanced Cell Diagnostics Recent Development
  • Table Aviva Biosciences Company Details
  • Table Aviva Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Aviva Biosciences Recent Development
  • Table Fluxion Biosciences Company Details
  • Table Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)(Million US$)
  • Figure Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2014-2019)
  • Table Fluxion Biosciences Recent Development
  • Table Sysmex Corporation Company Details
  • Table Epic Sciences Company Details
  • Table Cynvenio Company Details
  • Table CytoTrack Company Details
  • Table Ikonisys Company Details
  • Table Vortex BioSciences Company Details
  • Table Gilupi Company Details
  • Table Biocept Company Details
  • Table ScreenCell Company Details
  • Table ANGLE Company Details
  • Table Global Circulating Tumor Cell Market Size by Regions (Million US$) 2019-2025
  • Figure Global Circulating Tumor Cell Market Size Share by Regions (2019-2025)
  • Figure Global Circulating Tumor Cell Market Size Share by Regions in 2025
  • Figure United States Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure China Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure India Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Circulating Tumor Cell Market Size Forecast (2019-2025)(Million USD)
  • Table Global Circulating Tumor Cell Market Size by Product (2019-2025) (Million US$)
  • Figure Global Circulating Tumor Cell Market Size by Product (2019-2025)
  • Figure Global Circulating Tumor Cell Market Size by Product in 2025
  • Table Global Circulating Tumor Cell Market Size by Application (2019-2025) (Million US$)
  • Figure Global Circulating Tumor Cell Market Size by Application (2019-2025)
  • Figure Global Circulating Tumor Cell Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top